These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18294051)

  • 1. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
    Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
    Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
    Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
    Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes.
    Morak M; Massdorf T; Sykora H; Kerscher M; Holinski-Feder E
    Eur J Cancer; 2011 May; 47(7):1046-55. PubMed ID: 21195604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP.
    Ramsoekh D; van Leerdam ME; Tops CM; Dooijes D; Steyerberg EW; Kuipers EJ; Wagner A
    Clin Genet; 2007 Dec; 72(6):562-7. PubMed ID: 17922849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.
    Knopperts AP; Nielsen M; Niessen RC; Tops CM; Jorritsma B; Varkevisser J; Wijnen J; Siezen CL; Heine-Bröring RC; van Kranen HJ; Vos YJ; Westers H; Kampman E; Sijmons RH; Hes FJ
    Fam Cancer; 2013 Mar; 12(1):43-50. PubMed ID: 23007840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
    van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
    Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic c.34G>T KRAS mutation: a new prescreening test for MUTYH-associated polyposis?
    Aimé A; Coulet F; Lefevre JH; Colas C; Cervera P; Flejou JF; Lascols O; Soubrier F; Parc Y
    Cancer Genet; 2015; 208(7-8):390-5. PubMed ID: 26056087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC).
    Garre P; Briceño V; Xicola RM; Doyle BJ; de la Hoya M; Sanz J; Llovet P; Pescador P; Puente J; Díaz-Rubio E; Llor X; Caldés T
    Clin Cancer Res; 2011 Apr; 17(7):1701-12. PubMed ID: 21355073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited susceptibility to colorectal cancer.
    Rowley PT
    Annu Rev Med; 2005; 56():539-54. PubMed ID: 15660526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancers.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Lelièvre B; Olschwang S; Le Houérou C; Le Neel T; Faroux R; Ollivry J; Lafraise B; Chupin LD; Bézieau S
    Genet Test; 2007; 11(4):373-9. PubMed ID: 17931073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.
    Aretz S; Uhlhaas S; Goergens H; Siberg K; Vogel M; Pagenstecher C; Mangold E; Caspari R; Propping P; Friedl W
    Int J Cancer; 2006 Aug; 119(4):807-14. PubMed ID: 16557584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.
    Cao Y; Pieretti M; Marshall J; Khattar NH; Chen B; Kam-Morgan L; Lynch H
    Am J Gastroenterol; 2002 Jul; 97(7):1822-7. PubMed ID: 12135043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Adenomatous Polyposis: Heterogeneity of Susceptibility Gene Mutations and Phenotypes in a Cohort of Italian Patients.
    Marabelli M; Molinaro V; Abou Khouzam R; Berrino E; Panero M; Balsamo A; Venesio T; Ranzani GN
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):777-785. PubMed ID: 27705013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.